{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:44:52Z","timestamp":1790905492737,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1124\/jpet.104.067512","type":"journal-article","created":{"date-parts":[[2004,7,16]],"date-time":"2004-07-16T22:43:03Z","timestamp":1090017783000},"page":"745-751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Behavior of \u03b1-, \u03b2-, and \u03b3-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier"],"prefix":"10.1016","volume":"310","author":[{"given":"V.","family":"Monnaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tilloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bricout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Fenart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Cecchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Monflier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.104.067512_bib1","unstructured":"Anderson WR, Simpkins JW, Brewster ME, and Bodor N (1988) Brain-enhanced delivery of testosterone using a chemical delivery system complexed with 2-hydroxypropyl-\u03b2-cyclodextrin. Drug Des Deliv 2: 287-298."},{"key":"10.1124\/jpet.104.067512_bib2","doi-asserted-by":"crossref","unstructured":"Auzely-Velty R, Djeda\u00efni-Pilard F, Tache O, Zemb T, and Perly B (1999) Cholesteryl-cyclodextrins: new means to combine size specificity and liposome properties for the targeting of drugs. Carbohydr Res 318: 82-90.","DOI":"10.1016\/S0008-6215(99)00086-5"},{"key":"10.1124\/jpet.104.067512_bib3","unstructured":"Booher J and Sensenbrenner M (1972) Growth and cultivation of dissociated neurones and glial cells from embryonic chick, rat and human brain in flask cultures. Neurobiology 2: 97-105."},{"key":"10.1124\/jpet.104.067512_bib4","unstructured":"Bornstein MB (1958) Reconstituted rat tail collagen used as substrate for tissue cultures on coverlips in Maximow slides and roller tubes. Lab Investig 7: 134-139."},{"key":"10.1124\/jpet.104.067512_bib5","doi-asserted-by":"crossref","unstructured":"Camargo F, Erickson RP, Garver WS, Hossain GS, Carbone PN, Heidenreich RA, and Blanchard J (2001) Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci 70: 131-142.","DOI":"10.1016\/S0024-3205(01)01384-4"},{"key":"10.1124\/jpet.104.067512_bib6","doi-asserted-by":"crossref","unstructured":"Camilleri P, Haskins NJ, and Hewlett R (1994) \u03b2-Cyclodextrin interacts with the Alzheimer amyloid \u03b2-A4 peptide. FEBS Lett 341: 256-258.","DOI":"10.1016\/0014-5793(94)80467-2"},{"key":"10.1124\/jpet.104.067512_bib7","doi-asserted-by":"crossref","unstructured":"Cecchelli R, Dehouck B, Descamps L, Fenart L, Bu\u00e9e-Scherrer V, Duhem C, Lundquist S, Rentfel M, Torpier G, and Dehouck MP (1999) In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Delivery Rev 36: 165-178.","DOI":"10.1016\/S0169-409X(98)00083-0"},{"key":"10.1124\/jpet.104.067512_bib8","doi-asserted-by":"crossref","unstructured":"Dehouck MP, Dehouck B, Schluep C, Lemaire M, and Cecchelli R (1995) Drug transport to the brain: comparison between in vitro and in vivo models of the blood-brain barrier. Eur J Pharm Sci 3: 357-365.","DOI":"10.1016\/0928-0987(95)00028-5"},{"key":"10.1124\/jpet.104.067512_bib9","doi-asserted-by":"crossref","unstructured":"Dehouck MP, Jolliet-Riant P, Br\u00e9e F, Fruchart JC, Cecchelli R, and Tillement JP (1992) Drug transfer across the blood-brain barrier: in vitro and in vivo models. J Neurochem 58: 1790-1797.","DOI":"10.1111\/j.1471-4159.1992.tb10055.x"},{"key":"10.1124\/jpet.104.067512_bib10","doi-asserted-by":"crossref","unstructured":"Giocondi MC, Milhiet PE, Dosset P, and Le Grimellec C (2004) Use of cyclodextrin for AFM monitoring of model raft formation. Biophys J 86: 861-869.","DOI":"10.1016\/S0006-3495(04)74161-2"},{"key":"10.1124\/jpet.104.067512_bib11","doi-asserted-by":"crossref","unstructured":"Hovgaard L and Brondsted H (1995) Drug delivery studies in Caco-2 monolayers. Absorption enhancer effects of cyclodextrin. Pharm Res (NY) 12: 1328-1332.","DOI":"10.1016\/0378-5173(94)00232-T"},{"key":"10.1124\/jpet.104.067512_bib12","doi-asserted-by":"crossref","unstructured":"Hristova-Kazmierski MK, Horan P, Davis P, Yamamura HI, Kramer T, Horvath R, Kazmierski WM, Porreca F, and Hruby VJ (1993) A new approach to enhance bioavailability of biologically active peptides: conjugation of a \u03b4-opioid agonist to \u03b2-cyclodextrin. Bioorg Med Chem 3: 831-834.","DOI":"10.1016\/S0960-894X(00)80675-7"},{"key":"10.1124\/jpet.104.067512_bib13","doi-asserted-by":"crossref","unstructured":"Irie T and Uekama K (1997) Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86: 147-162.","DOI":"10.1021\/js960213f"},{"key":"10.1124\/jpet.104.067512_bib14","doi-asserted-by":"crossref","unstructured":"Legendre JY, Rault I, Luijten W, Demuynck I, and Horvath S (1995) Effects of \u03b2-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur J Pharm Sci 3: 311-322.","DOI":"10.1016\/0928-0987(95)00020-0"},{"key":"10.1124\/jpet.104.067512_bib15","doi-asserted-by":"crossref","unstructured":"Leppimaki P, Kronqvist R, and Slotte JP (1998) The rate of sphingomyelin synthesis de novo is influenced by the level of cholesterol in cultured human skin fibroblasts. Biochem J 335: 285-291.","DOI":"10.1042\/bj3350285"},{"key":"10.1124\/jpet.104.067512_bib16","doi-asserted-by":"crossref","unstructured":"Leroy-Lechat F, Wouessidjewe D, Andreux JP, Puisieux F, and Duch\u00eane D (1994) Evaluation of the cytotoxicity of cyclodextrins and hydroxypropylated derivatives. Int J Pharm (Amst) 101: 97-103.","DOI":"10.1016\/0378-5173(94)90080-9"},{"key":"10.1124\/jpet.104.067512_bib17","doi-asserted-by":"crossref","unstructured":"Lundquist S, Renftel M, Brillault J, Fenart L, Cecchelli R, and Dehouck MP (2002) Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharm Res (NY) 7: 976-981.","DOI":"10.1023\/A:1016462205267"},{"key":"10.1124\/jpet.104.067512_bib18","doi-asserted-by":"crossref","unstructured":"M\u00e9resse S, Dehouck MP, Delorme P, Bensaid M, Tauber JP, Delbart C, Fruchart JC, and Cecchelli R (1989) Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long term culture. J Neurochem 53: 1363-1371.","DOI":"10.1111\/j.1471-4159.1989.tb08526.x"},{"key":"10.1124\/jpet.104.067512_bib19","doi-asserted-by":"crossref","unstructured":"Merkus FW, Verhoef JC, Marttin E, Romeijn SG, van der Kuy PHM, Hermens WA, and Schiper NG (1999) Cyclodextrins in nasal drug delivery. Adv Drug Delivery Rev 36: 41-57.","DOI":"10.1016\/S0169-409X(98)00054-4"},{"key":"10.1124\/jpet.104.067512_bib20","doi-asserted-by":"crossref","unstructured":"Merkus FW, Verhoef JC, Romeijn SG, and Schiper NG (1991) Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats. Pharm Res (NY) 8: 588-592.","DOI":"10.1023\/A:1015896405389"},{"key":"10.1124\/jpet.104.067512_bib21","unstructured":"Miyajima K, Saito H, and Nakagaki M (1987) Destruction of liposomes by cyclodextrins. J Pharmacobio-Dyn 10: 123-128."},{"key":"10.1124\/jpet.104.067512_bib22","doi-asserted-by":"crossref","unstructured":"Moutard S, Perly B, God\u00e9 P, Demailly G, and Djeda\u00efni-Pilard F (2002) Novel glycolipids based on cyclodextrins. J Incl Phenom 44: 317-322.","DOI":"10.1023\/A:1023014718447"},{"key":"10.1124\/jpet.104.067512_bib23","doi-asserted-by":"crossref","unstructured":"Nakanishi K, Nadai T, Masada M, and Miyajima K (1992) Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement of the intestinal absorption of non-absorbable drug by cyclodextrins. Chem Pharm Bull 40: 1252-1256.","DOI":"10.1248\/cpb.40.1252"},{"key":"10.1124\/jpet.104.067512_bib24","doi-asserted-by":"crossref","unstructured":"Noji S, Takahashi T, and Kon H (1982) A spin-label study of the correlation between stomatocyte formation and membrane fluidization of erythrocytes. Biochem Pharmacol 31: 3173-3180.","DOI":"10.1016\/0006-2952(82)90546-9"},{"key":"10.1124\/jpet.104.067512_bib25","doi-asserted-by":"crossref","unstructured":"Ohtani Y, Irie T, Uekama K, Fukunaga K, and Pitha J (1989) Differential effects of \u03b1-, \u03b2- and \u03b3-cyclodextrins on human erythrocytes. Eur J Biochem 186: 17-22.","DOI":"10.1111\/j.1432-1033.1989.tb15171.x"},{"key":"10.1124\/jpet.104.067512_bib26","doi-asserted-by":"crossref","unstructured":"Ono N, Arima H, Hirayama F, and Uekama K (2001) A moderate interaction of maltosyl-\u03b1-cyclodextrin with Caco-2 cells in comparison with the parent cyclodextrin. Biol Pharm Bull 24: 395-402.","DOI":"10.1248\/bpb.24.395"},{"key":"10.1124\/jpet.104.067512_bib27","doi-asserted-by":"crossref","unstructured":"Ottico E, Prinetti A, Prioni S, Giannotta C, Basso L, Chigorno V, and Sonnino S (2003) Dynamics of membrane lipid domains in neuronal cells differentiated in culture. J Lipid Res 44: 2142-2151.","DOI":"10.1194\/jlr.M300247-JLR200"},{"key":"10.1124\/jpet.104.067512_bib28","doi-asserted-by":"crossref","unstructured":"Pitha J, Gerloczy A, and Olivi A (1994) Parenteral hydroxypropyl cyclodextrins: intravenous and intracerebral administration of lipophiles. J Pharm Sci 83: 833-837.","DOI":"10.1002\/jps.2600830615"},{"key":"10.1124\/jpet.104.067512_bib29","doi-asserted-by":"crossref","unstructured":"Siflinger-Birnboim A, Del Becchio PJ, Cooper JA, Blumenstock FA, Shepard JN, and Malik AB (1987) Molecular sieving characteristics of the cultured endothelial monolayer. J Cell Physiol 132: 111-117.","DOI":"10.1002\/jcp.1041320115"},{"key":"10.1124\/jpet.104.067512_bib30","doi-asserted-by":"crossref","unstructured":"Takakura Y and Hashida M (1996) Macromolecular carrier systems for targeted drug delivery: pharmacokinetic considerations on biodistribution. Pharm Res (NY) 13: 820-831.","DOI":"10.1023\/A:1016084508097"},{"key":"10.1124\/jpet.104.067512_bib31","doi-asserted-by":"crossref","unstructured":"Takeo K (1990) A convenient preparation of per-2,6-di-O-methylcyclomalto-oligosaccharide. Carbohydr Res 200: 481-485.","DOI":"10.1016\/0008-6215(90)84214-F"},{"key":"10.1124\/jpet.104.067512_bib32","doi-asserted-by":"crossref","unstructured":"Tanaka M, Iwata Y, Kouzuki Y, Taniguchi K, Matsuda H, Arima H, and Tsuchiya S (1995) Effect of 2-hydroxypropyl-\u03b2-cyclodextrin on percutaneous absorption of methyl paraben. J Pharm Pharmacol 47: 897-900.","DOI":"10.1111\/j.2042-7158.1995.tb03267.x"},{"key":"10.1124\/jpet.104.067512_bib33","doi-asserted-by":"crossref","unstructured":"Uekama K (1999) Cyclodextrins in drug delivery system. Adv Drug Delivery Rev 36: 1-2.","DOI":"10.1016\/S0169-409X(98)00055-6"},{"key":"10.1124\/jpet.104.067512_bib34","doi-asserted-by":"crossref","unstructured":"Yaksh TL, Jang JD, Nishiuchi Y, Braun KP, Ro SG, and Goodman M (1991) The utility of 2-hydroxypropyl-\u03b2-cyclodextrin as a vehicle for the intracerebral and intrathecal administration of drugs. Life Sci 48: 623-633.","DOI":"10.1016\/0024-3205(91)90537-L"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524314934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.104.067512","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:57:29Z","timestamp":1739998649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524314934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0022356524314934"],"URL":"https:\/\/doi.org\/10.1124\/jpet.104.067512","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavior of \u03b1-, \u03b2-, and \u03b3-Cyclodextrins and Their Derivatives on an in Vitro Model of Blood-Brain Barrier","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.104.067512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}